Comments to FDA: External Analgesic Drug Products for OTC Human Use Share page: Docket Number: 78N-0301 In this submission the task group provides updated data on the safety of counterirritants administered via patched or other novel dosage forms. Download Document Issues: OTC Medicines Related Posts Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Apr 25, 2024 Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024 Press Releases and Statements Self-Care Industry Representatives Participate in Capitol Hill Briefing Highlighting Legislative Priorities Apr 11, 2024